Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bright

Showing results (1-10 of 318) with videos related to

Pageof 32
Sort By:
The Journal of Hospital Infection|February 5, 2000
European medical device regulatory law and product liabilityJ Bright
Advances in Experimental Medicine and Biology|June 16, 2007
Curcumin and autoimmune diseaseJohn J Bright
Applied Clinical Informatics|January 24, 2014
Transforming user needs into functional requirements for an antibiotic clinical decision support system: explicating content analysis for system designT J Bright
Nutrition (Burbank, Los Angeles County, Calif.)|December 31, 2003
Targeting autoimmune diseases through nutraceuticalsJohn J Bright
Zoonoses and Public Health|November 17, 2020
Antimicrobial use data collection in animal agricultureSusan J Bright-Ponte
Bioscience Reports|April 1, 1994
Apoptosis: programmed cell death in health and diseaseJ Bright, A Khar
Journal of Anatomy|January 1, 1970
A comparative histochemical investigation into the localization of beta-D-glucuronidases in the rat kidneyB Ballantyne, J Bright
Journal of Clinical Immunology|May 9, 2008
15-deoxy-Delta(12,14)-prostaglandin J(2) and curcumin modulate the expression of toll-like receptors 4 and 9 in autoimmune T lymphocyteWanida Chearwae, John J Bright
British Journal of Cancer|November 20, 2008
PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cellsW Chearwae, J J Bright
Genes and Immunity|April 18, 2002
Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiationC Natarajan, J J Bright
Pageof 32

Showing results (1-10 of 318) with videos related to

Sort By:
Pageof 32
The Journal of Hospital Infection|February 5, 2000
European medical device regulatory law and product liabilityJ Bright
Advances in Experimental Medicine and Biology|June 16, 2007
Curcumin and autoimmune diseaseJohn J Bright
Applied Clinical Informatics|January 24, 2014
Transforming user needs into functional requirements for an antibiotic clinical decision support system: explicating content analysis for system designT J Bright
Nutrition (Burbank, Los Angeles County, Calif.)|December 31, 2003
Targeting autoimmune diseases through nutraceuticalsJohn J Bright
Zoonoses and Public Health|November 17, 2020
Antimicrobial use data collection in animal agricultureSusan J Bright-Ponte
Bioscience Reports|April 1, 1994
Apoptosis: programmed cell death in health and diseaseJ Bright, A Khar
Journal of Anatomy|January 1, 1970
A comparative histochemical investigation into the localization of beta-D-glucuronidases in the rat kidneyB Ballantyne, J Bright
Journal of Clinical Immunology|May 9, 2008
15-deoxy-Delta(12,14)-prostaglandin J(2) and curcumin modulate the expression of toll-like receptors 4 and 9 in autoimmune T lymphocyteWanida Chearwae, John J Bright
British Journal of Cancer|November 20, 2008
PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cellsW Chearwae, J J Bright
Genes and Immunity|April 18, 2002
Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiationC Natarajan, J J Bright
Pageof 32